Cargando…
Crystal structure of bis[dihydrobis(pyrazol-1-yl)borato-κ(2) N (2),N (2′)](1,10-phenanthroline-κ(2) N,N′)zinc(II)
The asymmetric unit of the title compound, [Zn(C(6)H(8)N(4)B)(2)(C(12)H(8)N(2))], comprises one half of a Zn(II) cation (site symmetry 2), one dihydrobis(pyrazol-1-yl)borate ligand in a general position, and one half of a phenanthroline ligand, the other half being completed by twofold rotation s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690474/ https://www.ncbi.nlm.nih.gov/pubmed/31417775 http://dx.doi.org/10.1107/S2056989019009289 |
Sumario: | The asymmetric unit of the title compound, [Zn(C(6)H(8)N(4)B)(2)(C(12)H(8)N(2))], comprises one half of a Zn(II) cation (site symmetry 2), one dihydrobis(pyrazol-1-yl)borate ligand in a general position, and one half of a phenanthroline ligand, the other half being completed by twofold rotation symmetry. The Zn(II) cation is coordinated in form of a slightly distorted octahedron by the N atoms of a phenanthroline ligand and by two pairs of N atoms of symmetry-related dihydrobis(pyrazol-1-yl)borate ligands. The discrete complexes are arranged into columns that elongate in the c-axis direction with a parallel alignment of the phenanthroline ligands, indicating weak π–π interactions. |
---|